Lykos & MDMA Decision: Psychedelic Bar Association Board of Directors Statement

This is what they have said The FDA’s rejection of Lykos’ NDA reveals a deeper communal quandary, especially in light of the agency’s inability to assess a human-based intervention combined with a chemical drug. Are we really ready to incorporate psychedelics into regular old American life? By: The Psychedelic Bar Association Board of Directors The recent […]